|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030685,
umls-concept:C0078058,
umls-concept:C0087111,
umls-concept:C0221928,
umls-concept:C0302600,
umls-concept:C0332161,
umls-concept:C0380603,
umls-concept:C0391871,
umls-concept:C0439834,
umls-concept:C0680255,
umls-concept:C1256770,
umls-concept:C1283071,
umls-concept:C1515655,
umls-concept:C1533691,
umls-concept:C1963578
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-4-26
|
|
pubmed:abstractText |
Angiogenesis can be enhanced by several growth factors, like vascular endothelial growth factor-165 (VEGF(165)) and basic fibroblast growth factor (bFGF). Delayed release of such growth factors could be provided by incorporation of growth factors in fibrin matrices. In this study, we present a slow release system for VEGF(165) and bFGF in fibrin sealant.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chondroitin Sulfates,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Tissue Adhesive,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/integra artificial skin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1435-2443
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
392
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
305-14
|
|
pubmed:meshHeading |
pubmed-meshheading:17404752-Animals,
pubmed-meshheading:17404752-Chondroitin Sulfates,
pubmed-meshheading:17404752-Collagen,
pubmed-meshheading:17404752-Delayed-Action Preparations,
pubmed-meshheading:17404752-Drug Delivery Systems,
pubmed-meshheading:17404752-Endothelium, Vascular,
pubmed-meshheading:17404752-Fibrin,
pubmed-meshheading:17404752-Fibrin Tissue Adhesive,
pubmed-meshheading:17404752-Fibroblast Growth Factor 2,
pubmed-meshheading:17404752-Mice,
pubmed-meshheading:17404752-Mice, Nude,
pubmed-meshheading:17404752-Neovascularization, Physiologic,
pubmed-meshheading:17404752-Recombinant Proteins,
pubmed-meshheading:17404752-Skin,
pubmed-meshheading:17404752-Time Factors,
pubmed-meshheading:17404752-Vascular Endothelial Growth Factor A,
pubmed-meshheading:17404752-Wound Healing
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo.
|
|
pubmed:affiliation |
Department of Plastic Surgery, Burn Unit, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. i.wilcke@web.de
|
|
pubmed:publicationType |
Journal Article
|
